Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05704595

Effectiveness of Outpatient Intravenous Diuretic Therapy for Treatment of Worsening Heart Failure (OUTPATIENT-WHF)

Conditions: Heart Failure

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 70
Sponsor: Duke University

Summary

The purpose of the OUTPATIENT-WHF study is to characterize the effectiveness of outpatient intravenous diuretic therapy as a treatment for worsening heart failure.

Eligibility Criteria

Inclusion Criteria:≥18 years of agePresentation to a Duke outpatient clinic with heart failure requiring IV diuretics, as per clinician judgementAble to provide signed informed consentSuccessful completion of EuroQOL-5 dimensions surveyExclusion Criteria:Managing clinician without equipoise for initial outpatient treatment strategy versus initial hospitalization-based treatment strategy for heart failure, and decline to accept randomization.Patient without equipoise for initial outpatient treatment strategy versus initial hospitalization-based treatment strategy for heart failure, and decline to accept randomization.History of left ventricular assist device or heart transplantationEnd-stage kidney disease requiring chronic dialysis therapyNew diagnosis of heart failurePregnant or breast-feedingFever >101.0 degrees Fahrenheit at screeningAny other condition that in the judgment of the investigator would jeopardize the patient's compliance with the study protocol

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05704595). StuddyBuddy aggregates publicly available trial information.